To evaluate the efficacy of intravenous heparin in the prevention of stroke progression or death in patients with acute partial stable stroke.
- Heparin (acute stroke) Drug
Intervention Desc: Intravenous anticoagulant.
Randomized, double-blind, placebo-controlled trial of 225 patients at 3 centers.
Patients were randomized to receive intravenous heparin or placebo for 7 days. Follow-up period of 1 year.
|Type||Measure||Time Frame||Safety Issue|
|Primary||Degree of stroke progression as determined by changes in focal neurologic score, or number of deaths during 7-day treatment period.|